Precision Optics Corp Inc (POCI)
5.41
-0.14
(-2.52%)
USD |
NASDAQ |
May 03, 16:00
Precision Optics 1 Year Total Returns (Daily): -13.44% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -13.44% |
May 02, 2024 | -9.76% |
May 01, 2024 | -8.87% |
April 30, 2024 | -11.11% |
April 29, 2024 | -11.11% |
April 26, 2024 | -10.58% |
April 25, 2024 | -11.13% |
April 24, 2024 | -13.05% |
April 23, 2024 | -13.44% |
April 22, 2024 | -14.06% |
April 19, 2024 | -16.29% |
April 18, 2024 | -15.80% |
April 17, 2024 | -16.76% |
April 16, 2024 | -16.64% |
April 15, 2024 | -16.64% |
April 12, 2024 | -12.64% |
April 11, 2024 | -19.52% |
April 10, 2024 | -16.91% |
April 09, 2024 | -17.89% |
April 08, 2024 | -17.43% |
April 05, 2024 | -17.49% |
April 04, 2024 | -10.68% |
April 03, 2024 | -10.78% |
April 02, 2024 | -15.76% |
April 01, 2024 | -15.76% |
Date | Value |
---|---|
March 28, 2024 | -8.57% |
March 27, 2024 | -7.83% |
March 26, 2024 | -2.10% |
March 25, 2024 | -1.67% |
March 22, 2024 | -2.30% |
March 21, 2024 | -8.03% |
March 20, 2024 | -1.65% |
March 19, 2024 | -3.74% |
March 18, 2024 | -5.10% |
March 15, 2024 | -11.86% |
March 14, 2024 | -20.17% |
March 13, 2024 | -16.14% |
March 12, 2024 | -14.40% |
March 11, 2024 | -14.24% |
March 08, 2024 | -19.83% |
March 07, 2024 | -21.42% |
March 06, 2024 | -19.50% |
March 05, 2024 | -26.11% |
March 04, 2024 | -24.72% |
March 01, 2024 | -23.62% |
February 29, 2024 | -23.40% |
February 28, 2024 | -23.55% |
February 27, 2024 | -20.42% |
February 26, 2024 | -18.45% |
February 23, 2024 | -16.04% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-44.44%
Minimum
Sep 25 2020
192.2%
Maximum
May 08 2019
20.01%
Average
10.37%
Median
Aug 30 2019
1 Year Total Returns (Daily) Benchmarks
AptarGroup Inc | 24.03% |
Daxor Corp | -13.58% |
Sanara MedTech Inc | -17.35% |
Warby Parker Inc | 11.03% |
Perspective Therapeutics Inc | 196.0% |